Better Health for All
0
No evidence available to assess Repligen Corporation on Better Health for All.
Fair Money & Economic Opportunity
0
Repligen Corporation is a bioprocessing company focused on manufacturing products for biologics. Its core business does not involve offering lending, deposit, or other financial services to consumers.
1
Consequently, all KPIs under the 'Fair Money & Economic Opportunity' value, which are designed for financial institutions, are not applicable to Repligen.
2
The provided articles consistently state 'No data found' or 'Not applicable' for metrics such as underserved client share, pricing fairness, exploitative fee exposure, inclusion initiatives, data accessibility, fair lending compliance, wealth-building outcomes, profit reinvestment in community finance, financial literacy initiatives, debt burden ratio, geographic inclusion, and product simplicity.
3
General corporate donations mentioned in the reports are not specific to community finance reinvestment as defined by the rubric.
Fair Pay & Worker Respect
-20
In 2024, the company's CEO pay ratio was 69:1, with the CEO earning $7,184,359 and the median employee earning $104,324.
1
In 2022, approximately 10% of the total workforce was covered by collective bargaining agreements, comprising 6% in Sweden and 4% in France.
2
A discrimination case was filed against Repligen Corporation in July 2025, alleging systemic gender discrimination and retaliation.
3
Additionally, an employee review from September 2023 alleged "forced labor" and required work on national holidays, and another from August 2023 alleged disregard for employee safety and health.
4
Fair Trade & Ethical Sourcing
-50
Repligen's critical suppliers are audited either on-site or remotely every 3-5 years.
1
The company reported zero substantiated forced or child labor findings in the last 3 years (2022-2024), and no significant risk for such incidents was identified in 2023 or 2024.
2
Repligen's Business Partner Code of Conduct sets expectations for suppliers regarding human rights and fair labor practices, and the company's business conduct policies reflect high ethical standards for partners.
3
In 2024, a supplier and material risk framework was implemented, and the company is rated Low Risk by Morningstar Sustainalytics.
4
However, the proportion of spending on local suppliers was not tracked in 2023.
5
While traceability is maintained for incoming raw materials and outgoing products via barcoded labels and batch/lot numbers, there is no evidence of mapping beyond tier 1.
6
No new suppliers were screened using social or environmental criteria in 2023.
7
Honest & Fair Business
-20
Repligen reported no significant instances of noncompliance with laws or regulations and no ethics-related fines paid in 2023 or 2024.
1
The company has a formal whistleblower policy with multiple direct and anonymous channels, including a hotline managed by NAVEX Global, and explicitly prohibits retaliation.
2
However, no reports were submitted via this grievance mechanism in 2023.
3
The company will restate its consolidated financial statements for the year ended December 31, 2023, and for quarterly periods in 2023 and 2024, due to the misapplication of accounting principles related to a COVID-related cancellation payment, and identified a material weakness in internal control over financial reporting.
4
The company's sustainability reports are not externally assured, except for audited financial data, and it reported 0% third-party audit coverage for manufacturing and product quality facilities and Tier 1 suppliers.
5
Repligen maintained an MSCI AA “Leader” rating and was rated Low Risk by Morningstar Sustainalytics.
6
Eight of nine directors are independent.
7
The company has comprehensive anti-corruption policies, including a Business Partner Code of Conduct, and conducted anti-bribery and anti-corruption training for 74% of employees in 2024.
8
Kind to Animals
-60
Repligen's Business Partner Code of Conduct (April 2025 and April 2021) states that business partners shall minimize animal experiments and suffering, indicating that animal testing is part of their operations.
1
2
The company uses animals for drug testing and clinical trials, conducting pre-clinical trials on animals.
3
While they also utilize cell-based assays for virus titration as an alternative method, the use of animals for drug testing suggests that non-animal methods are not universally applied.
4
For wildlife conservation, the Estonia facility preserved a 150-year-old oak tree, and the Lund, Sweden team installed six habitat boxes for winged wildlife.
5
The company's R&D investment for 2020-2022 was 5% to 6% of revenue, but there is no specific percentage allocated to animal-free technologies.
6
A pilot study for supplier audits covered 12% of suppliers for emissions assessment, but 0% of facilities and Tier 1 suppliers participate in third-party audit programs for manufacturing and product quality, with evaluation for 2025 and beyond.
7
8
The company does not report the number of animals used in testing annually.
No War, No Weapons
-20
Repligen Corporation is a bioprocessing company, and its 10-K filing explicitly states that it is not a defense contractor, indicating no revenue from arms or defense contracts.
1
The company's R&D is focused on bioprocessing technologies, and dual-use technologies with military applications are noted as not applicable.
2
The company mentions alignment with the UN Global Compact and ESG initiatives in its 10-K filing and sustainability reports, which supports UN Guiding Principles on Business and Human Rights in principle.
3
Planet-Friendly Business
-50
In 2024, Repligen's total Scope 1, 2, and 3 greenhouse gas emissions were 22,057 tCO2e, comprising 1,728 tCO2e for Scope 1, 0 tCO2e for Scope 2, and 20,329 tCO2e for Scope 3.
1
The company has committed to net-zero emissions by 2050 with the Science Based Targets initiative (SBTi) and submitted a commitment letter in December 2023, with a plan to be submitted for approval by the end of 2025.
2
All 19 manufacturing sites are powered by 100% renewable electricity, representing 100% of global total consumption.
3
In 2024, water withdrawal intensity was 191.8 m³ per $1M revenue, and less than 10% of global water withdrawals came from water-stressed regions.
4
The Estonia facility is under review for LEED Silver certification.
5
In 2024, 68% of total waste was diverted from landfill, and total waste generation was reduced by 25% compared to 2023.
6
Boxes contain at least 40% recycled content, and the Clifton Park, NY site achieved an 80% reuse rate for nylon material recycling.
7
Repligen expanded its Scope 3 emissions inventory to 11 of 15 material categories in 2024, including partial data for Use of Sold Products and End-of-Life Treatment of Sold Products for select products.
8
No significant environmental compliance violations or fines were identified in 2023 or 2024.
9
The 2023 Sustainability Report includes detailed disclosures aligned with the Task Force on Climate-Related Financial Disclosures (TCFD), and the company describes the resilience of its strategy considering a 2-degree or lower climate scenario.
10
Packaging for Spectrum® Hollow Fiber Filters resulted in an 83% reduction in shipping-related carbon emissions.
11
The company is in the initial stages of evaluating biodiversity impacts and has installed habitat boxes and preserved an oak tree.
12
Supplier questionnaires and audits are conducted every 3-5 years.
13
Respect for Cultures & Communities
-10
Repligen reported no cultural appropriation incidents in its 2022 sustainability report, and later reports state no specific data or no identified incidents of violations involving indigenous rights.
1
The company does not have a specific cultural impact assessment protocol, as its operations are not identified to impact cultural contexts.
2
Repligen maintains accessible, confidential, and effective grievance mechanisms, including a Compliance Hotline, to address human rights concerns and improper conduct.
3
Free, Prior and Informed Consent (FPIC) processes are not applicable to the company's operations.
4
There is no specific community representation on governance bodies.
5
No specific funding is allocated to cultural or linguistic preservation programs.
6
The company does not track indigenous or minority-owned suppliers.
7
Repligen's operations are not identified to impact cultural or heritage sites.
8
The concept of social license to operate is not applicable to the business model.
9
The company engages in general charitable giving, but no specific percentage of revenue is donated to cultural heritage organizations.
10
No specific non-core revenue is distributed to community development funds.
11
There is no specific data on language inclusivity in products and communications.
12
The company does not have a specific cultural incident response framework.
13
No specific data is provided on cultural sensitivity training completion rates for employees.
14
The proportion of spending on local suppliers was not tracked in 2023.
15
Safe & Smart Tech
0
Repligen sustained a cybersecurity awareness training completion rate above 95% in both 2023 and 2024.
1
Employees receive mandatory quarterly security and awareness training, plus monthly phishing simulations.
2
The company has set up diverse AI policies, including an AI Usage Policy, and created an AI Task Force.
3
Repligen replaced traditional multi-factor authentication (MFA) with a passkey solution.
4
The company uses continuous vulnerability management and autonomous penetration testing for continuous vulnerability scanning.
5
Security measures were rigorously validated by a third-party security assessment firm.
6
Repligen deploys information security systems to meet regulatory and customer obligations, adheres to the CIS 20 Controls framework, and has implemented a global Personal Data Protection Policy.
7
They also expanded their Data Privacy program to the APAC region, addressing China's DSL, PIPL, and CSL, and provide training on GDPR adherence.
8
A cybersecurity incident involving unauthorized access to certain files was discovered on July 9, 2024, and contained by July 15, 2024.
9
The company believes no malware encryption occurred and does not expect the event to materially affect its financial health or operational results.
10
In 2023, there were no substantiated complaints received concerning breaches of customer privacy from outside parties or regulatory bodies.
11
The company implemented a robust application allowlist solution to reduce the risk of malware and unauthorized software.
12
Zero Waste & Sustainable Products
-50
In 2022, Repligen diverted 21% of its total waste from disposal.
1
The company reported no waste disposal violations or fines in the past three years.
2
Repligen reduced total waste generation by 25% and waste intensity by 32% compared to 2023.
3
Specific waste reduction initiatives include a 74% reduction in ceramic scrap at the Gothenburg site, a 50% reduction in clean room glove waste at the Clifton Park site, and a 75% reduction in plastic waste and 18% reduction in corrugated fiberboard waste through optimized packaging design for ValiChrom columns.
4
The company also switched to 100% fiber-based, fully recyclable inserts for some products.
5
Repligen applies circular design principles in product design, such as optimizing packaging and reusing materials, and has company-wide waste reduction targets, though specific details are not provided.
6
No formal product take-back, reuse, or recycling program is currently offered.
7
The company's Business Partner Code of Conduct requires suppliers to comply, but specific waste reduction or recyclability requirements are not detailed.
8